Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30854320 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL30854304 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL17931825 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL9961490 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL16968414 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL16491025 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL27398 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL13998184 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL342905 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL30854383 | 1.00 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903386-A | Method for realizing liquid phase polymerization of high-concentration polyhydroxy aldehyde or (and) polyhydroxy ketone through liquid thereof under high-temperature condition | 厦门碳控科技投资有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-110226640-A | A kind of full nutrient formulation powder and its manufacturing method | 宁波特壹食品有限公司 | 2019-09-13 | — | — | CN | claimed |
| CN-109172627-A | The preparation method of cactus fine powder | 健掌（上海）生物科技有限公司 | 2019-01-11 | — | — | CN | claimed |
| US-20110027803-A1 | Compositions and Methods for Maintenance of Fluid Conducting and Containment Systems | LUX INNOVATE LTD. (GB) | 2011-02-03 | — | — | US | claimed |
| US-20100304418-A1 | Compositions and Methods for Monitoring Flow Through Fluid Conducting and Containment Systems | LUX INNOVATE LTD. (GB) | 2010-12-02 | — | — | US | claimed |
| US-20100297159-A1 | THOMSEN-FRIEDENREICH DISACCHARIDE MODIFIED IMMUNOGEN (TFD), PREPARATION PROCEDURE, COMPOSITIONS COMPRISING IT, USES, AND TREATMENT METHODS | CONSEJO NACIONAL DE INVESTIGACIONES CIETIFICAS Y TECNICAS (CONICET) (AR) | 2010-11-25 | — | — | US | claimed |
| EP-2235199-A1 | COMPOSITIONS AND METHODS FOR MAINTENANCE OF FLUID CONDUCTING AND CONTAINMENT SYSTEMS | Lux Innovate Limited (GB) | 2010-10-06 | — | — | EP | claimed |
| EP-2219667-A2 | THOMSEN-FRIEDENREICH DISACCHARIDE MODIFIED IMMUNOGEN (TFD), PREPARATION PROCEDURE, COMPOSITIONS COMPRISING IT, USES, AND TREATMENT METHODS | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) (AR) | 2010-08-25 | — | — | EP | claimed |
| WO-2009077760-A1 | COMPOSITIONS AND METHODS FOR MAINTENANCE OF FLUID CONDUCTING AND CONTAINMENT SYSTEMS | LUX INNOVATE LIMITED (GB) | 2009-06-25 | — | — | WO | claimed |
| WO-2009066245-A2 | THOMSEN-FRIEDENREICH DISACCHARIDE MODIFIED IMMUNOGEN (TFD), PREPARATION PROCEDURE, COMPOSITIONS COMPRISING IT, USES, AND TREATMENT METHODS | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) (AR) | 2009-05-28 | — | — | WO | claimed |
| CN-122036817-A | C-alkyl carbon glycoside and preparation method thereof | 江西师范大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-119736207-B | Chitin-philic bacteria and use thereof | 云南大学 | 2026-02-27 | — | — | CN | disclosed |
| US-20260026508-A1 | Seed Treatment Formulations and Methods of Use | PUNA BIO CORP (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250362306-A1 | METHODS FOR ANALYZING PROTEOMIC ATTRIBUTES OF BIOLOGICAL SAMPLES, AND RELATED SYSTEMS AND APPARATUS | CALICO LIFE SCIENCES LLC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4605371-A1 | POLYOL-DERIVED COMPOUNDS | Arxada AG (CH) | 2025-08-27 | — | — | EP | disclosed |
| WO-1994018340-A1 | ALTEROMONAS-TYPE BACTERIA, POLYSACCHARIDES PRODUCED BY SAID BACTERIA, OSE CONTAINED IN SAID POLYSACCHARIDES AND APPLICATIONS | INSTITUT FRANÇAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER - IFREMER (FR) | 1994-08-18 | — | — | WO | disclosed |
| US-5292662-A | Position-specific insertion vectors and method of using same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0445227-A4 | POSITION-SPECIFIC INSERTION VECTORS AND METHOD OF USING SAME | — | 1991-12-27 | — | — | EP | disclosed |
| EP-0445227-A1 | POSITION-SPECIFIC INSERTION VECTORS AND METHOD OF USING SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-09-11 | — | — | EP | disclosed |
| WO-1990005787-A1 | POSITION-SPECIFIC INSERTION VECTORS AND METHOD OF USING SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026508-A1 | Seed Treatment Formulations and Methods of Use | PGLS, GNE, GALE | PDE4A 3162/4885LMNA 2892/4885L3MBTL1 3800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.